Trastuzumab Deruxtecan Versus Ramucirumab And Paclitaxel As Second-Line Therapy For Patients With Her2-Positive Gastric Or Gastro-Esophageal Junction Adenocarcinoma: A Propensity Score Matched Comparison
Trastuzumab Deruxtecan;Paclitaxel;Ramucirumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Trastuzumab Deruxtecan Versus Ramucirumab And Paclitaxel As Second-Line Therapy For Patients With Her2-Positive Gastric Or Gastro-Esophageal Junction Adenocarcinoma: A Propensity Score Matched Comparison ### Output: Trastuzumab Deruxtecan;Paclitaxel;Ramucirumab